Ketoprofen EP Impurity J

IMPURITIES

CAT No.# CS-P-05001
Category Impurities
CAS 1785759-59-2
Stock Status
IN-STOCK HAVE QUESTIONS ? View COA
Molecular Weight 282.33
Molecular Formula C18H18O3
Synonyms: 2-[3-(2,4-Dimethylbenzoyl)phenyl]propanoic acid
Application Notes: Ketoprofen, is one of the propionic acid class of nonsteroidal anti-inflammatory drugs with analgesic and antipyretic effects. It acts by inhibiting the body's production of prostaglandin. Ketoprofen is generally prescribed for arthritis-related inflammatory pains or severe toothaches that result in the inflammation of the gums.
References: Ueno, K., et al.: J. Med. Chem., 19, 941 (1976); Liversidge, G.G., Anal. Profiles Drug Subs., 10, 443 (1981); Jamali, F., et al.: Clin. Pharmacokinet., 19, 197 (1990)
Shipping: Free Shipping for worldwide on order above 2000 USD
Ketoprofen EP Impurity J Worldwide Suppliers of Ketoprofen EP Impurity J Impurities Clearsynth CS-P-05001

Product rating: 9 Ketoprofen EP Impurity J based on 20 ratings

  1. Impurities
  2. Ketoprofen EP Impurity J


PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. 1-Octadecanethiol
20. H-Ser(Bzl)-OBzl . p-tosylate (E-3755.0005)


This page contains information about Ketoprofen EP Impurity J Cas 1785759-59-2 and its Impurities.

Ketoprofen EP Impurity J Ketoprofen EP Impurity J Worldwide Suppliers of Ketoprofen EP Impurity J Impurities Clearsynth 1785759-59-2

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."